DOCSLIB.ORG

International Session Poster 一般ポスター

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International Session Poster 一般ポスター Web 閲覧 International Session Poster 一般ポスター ※本プログラムの演題名・氏名・所属の表記は、ご自身による表記を 優先いたしましたが、統一のため多少変更を加えた部分があります。 KLQSBWZHELQGG KLQSBWZHELQGG International Session Poster 01 ◆ Andrology ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-01 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-02 Results of Assisted Reproductive Treatment in Azoospermic Patients Batmunkh Ganbat（Infertility and Reproductive Center, Mongolian National Center for Maternal and Child Health, Mongolia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-03 Bilateral inguinal hernia diagnosed and treatment on laparoscopic varicocelectomy Erdenebaatar Baljinnyam（Surgical Department, MD, Surgeon of Central Hospital of Arkhangai Aimag, Mongolia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-04 Is there any difference of safety between an acellular dermal matrix（allograft VS. xenograft）used for penile augmentation surgery during the early period? Sungwoo Hong（Urology, Yezak Hospital, Korea） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-05 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-06 Evaluation of Extra-Corporeal Shock Wave Therapy for The Patients of Peyronies Disease Rajendra Kashinath K Shimpi（Urology, Andrology, Robotic Surgery, Ruby Hall Clinic, Postgraduate Institute, India） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-07 Withdrawn W ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ e ISP01-08 Penile Dorsal Neurectomy Results: Correlation Between Penile Ejaculation and Emotional b 閲 Distress 覧 Todnombat Davaasuren（Department of Surgery, Tod Gangnam Plastic Surgery Clinic, Mongolia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-09 Case series: Two cases of complications with penile prosthesis Shin Mei Wong（Urology, Cardinal Tien Hospital, Taiwan） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-10 Polyarteritis Nodosa-Vasculitis causing testicular infarction Dorothy Chua（Department of Urology, Ipswich Hospital, Australia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP01-11 Acute Scrotum in a Young Male: A Rare Presentation of Zinner Syndrome Amaresh Mohan（Manipal Academy of Higher Education, India） International Session Poster 02 ◆ Urothelial Tumors and Others ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-01 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-02 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-03 Prognostic impact of postoperative acute kidney injury after radical cystectomy Tomoyo Kurisu（Department of Urology, Sapporo Medical University, Japan） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-04 Subcorneal pustule over surgical wound after radical cystectomy-A very rare case report Yian Liao（Urology Department, National Taiwan University Hospital, Taiwan） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-05 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-06 Withdrawn ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-07 Primary large cell neuroendocrine carcinoma of the ureter: Case report and literature re- view Chin Tang（Division of Urology, Department of Surgery, Cathay General Hospital, Taiwan） 第108回日本泌尿器科学会総会 129 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-08 The investigation of a traditional Chinese medicine, Trichosanthes kirilowii Fruits as an therapeutic agent for urothelial carcinoma of the bladder Jiang Ning（Tianjin Institute of Urology, China） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-09 Use of Ileum for Complex Ureteral Reconstruction: A Single Centre Experience Sheshang U Kamath（K.E.M Hospital, India） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-10 The P53 Codon 72 Polymorphism in Mongolian Patients with Bladder Cancer Batmunkh Ganbat（School of Medicine, Department of Surgery, Division of Urology, Mongolian National University of Medical Sci- ences, Mongolia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP02-11 Withdrawn International Session Poster 03 ◆ Urothelial Tumors ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ISP03-01 Radical cystectomy for muscle-invasive bladder cancer: Do younger patientshavebetter outcomes? Hamza Boussaffa（Urology Department, Charles Nicolle Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia） ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ W ISP03-02 Two cycles of neoadjuvant chemotherapy improves survival of upper tract urothelial car- e cinoma patients b 閲 Kenji Zennami（Department of Urology, Fujita Health University, Japan） 覧 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Load more

Recommended publications
  • Fine Tuning HCN Channel Activity Tural Basis of This Coupling Has Only Been Well Characterized in Kcsa
    Wednesday, February 15, 2017 465a Symposium: Protein Dynamics and Allostery example, in-silico models of human cardiac electrophysiology are being considered by the FDA for prediction of proarrhythmic cardiotoxicity as a 2285-Symp core component of the preclinical assessment phase of all new drugs. How- Coupled Residue-Residue Dynamics in Protein Allosteric Mechanisms ever, one issue that exists with current models is that they each respond Donald Hamelberg. differently to insults such as drug block of ion channels or mutation of cardiac Department of Chemistry, Georgia State University, Atlanta, GA, USA. ion channel genes. Clearly this poses a problem in relation to the utility of Although the relationship between structure and function in biomolecules is these models in making quantitative predictions that are physiologically or well established, it is not always adequate to provide a complete understanding clinically meaningful. To examine this in detail we tested the ability of three of biomolecular function. The dynamical fluctuations of biomolecules can also models of the human ventricular action potential, the O’hara-Rudy the Grandi- play an essential role in function. Detailed understanding of how conforma- Bers and the Ten Tusscher models, to reproduce the clinical phenotype of tional dynamics orchestrates function in allosteric regulation of recognition different subtypes of the long QT syndrome. All models, in their original and catalysis at atomic resolution remains ambiguous. The overarching goal form, produce markedly different and unrealistic predictions of QT prolonga- is to understand how biomolecular dynamics are coupled to function by using tion. To address this, we used a global optimization approach to constrain ex- atomistic molecular simulations to complement experiments.
    [Show full text]
  • CNPY2 Inhibits MYLIP-Mediated AR Protein Degradation in Prostate Cancer Cells
    www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 25), pp: 17645-17655 Research Paper CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells Saya Ito1,*, Akihisa Ueno1,*, Takashi Ueda1,2, Hideo Nakagawa1, Hidefumi Taniguchi1, Naruhiro Kayukawa1, Atsuko Fujihara-Iwata1, Fumiya Hongo1, Koji Okihara1 and Osamu Ukimura1 1Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto-City, Kyoto 602-8566, Japan 2Department of Urology, Uji Takeda Hospital, Uji-City, Kyoto 611-0021, Japan *These authors equally contributed to this work Correspondence to: Takashi Ueda, email: [email protected] Keywords: CNPY2; prostate cancer; AR; MYLIP; protein degradation Received: September 29, 2017 Accepted: March 01, 2018 Published: April 03, 2018 Copyright: Ito et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The androgen receptor (AR) is a ligand-dependent transcription factor that promotes prostate cancer (PC) cell growth through control of target gene expression. This report suggests that Canopy FGF signaling regulator 2 (CNPY2) controls AR protein levels in PC cells. We found that AR was ubiquitinated by an E3 ubiquitin ligase, myosin regulatory light chain interacting protein (MYLIP) and then degraded through the ubiquitin-proteasome pathway. CNPY2 decreased the ubiquitination activity of MYLIP by inhibition of interaction between MYLIP and UBE2D1, an E2 ubiquitin ligase. CNPY2 up-regulated gene expression of AR target genes such as KLK3 gene which encodes the prostate specific antigen (PSA) and promoted cell growth of PC cells.
    [Show full text]
  • October 7 (Friday) October 7 the 75Th Annual Meeting of the Japanese Cancer Association Cancer Japanese of the Meeting Annual the 75Th Room 4 Oct
    INFORMATION The 75th Annual Meeting of the Japanese Cancer Association DAY 1 AM PM Day 2 LS October 7 (Friday) Posters DAY 2 AM LS PM Posters DAY 3 AM PM Posters LS INDEX Authors Keywords Chairpersons 125 Room 4 Oct. 7 (Fri.) 8:00-8:50 E Room 8 Oct. 7 (Fri.) 8:00-8:50 J Potential cancer therapeutics targeting TGF-β/Smad3 From Real-time Tumor-Tracking Technology to Motion ML1 signaling ML5 Science in Life 動体追跡技術から生体の動きの科学へ Chairperson: Susumu Itoh (BioChem., Showa Pharm. Univ.) 座長：伊東 進（昭和薬大・生命薬学・生化学） Chairperson: Masahiko Miura (Tokyo Med. & Dent. Univ.) 座長：三浦 雅彦（東京医歯大・院医歯・口腔放射線腫瘍） ML1 Potential cancer therapeutics targeting TGF-β/Smad3 signaling ML5 From Real-time Tumor-Tracking Technology to Motion Seong-Jin Kim1, Eunjin Bae1, Jinah Park1, Mi-Kyung Kwak1, Kazuhito Science in Life Naka2, Ooshima Akira1 (1Nanobio Med. Res. Ctr., AICT, Seoul Natl. Hiroki Shirato1,2 (1Dept. Radiat. Med., Grad. Sch. Med. Hokkaido Univ., Univ., 2Res. Inst. for Radiation Biol. & Med., Hiroshima Univ.) 2Quant. Med. Sci. Eng., Glob. Inst. Res. Ed., Hokkaido Univ.) 動体追跡技術から生体の動きの科学へ 白土 博樹 1,2（1 北海道大・医・放医、2 北海道大・国際連携・量子医 理工） Room 5 Oct. 7 (Fri.) 8:00-8:50 J Room 9 Oct. 7 (Fri.) 8:00-8:50 J RUNX genes: Integral component of Fanconi-BRCA pathway In situ Delivery and Production System(iDPS) to Target ML2 ML6 Hypoxia of Solid Cancers with Anaerobic Bifidobacterium 嫌気性ビフィズス菌を用いた固形がんの嫌気的環境を標的とする選択的・持続的抗がん物質の産生系 Chairperson: Rieko Ooki (Natl. Cancer Ctr.) 座長：大木 理恵子（国立がん研究セ・研・難治がん） Chairperson: Shinae Kondoh (Sch. of Life Sci. &d Tech., Tokyo Inst.
    [Show full text]
  • September 28 (Thursday) September the 76Th Annual Meeting of the Japanese Cancer Association Cancer Japanese of the Meeting Annual the 76Th 0-1 1-2
    INFORMATIONDAY 1 AM LS PM Posters DAY 2AMLS PM Posters DAY 3 AMLS PM Posters INDEX Authors Keywords Chairpersons 61 1 Day September 28 (Thursday) The 76th Annual Meeting of the Japanese Cancer Association Cancer Meeting of the Japanese Annual The 76th 0-1 1-2 Core Symposia Symposia Room 1 Sept. 28 (Thu.) 9:00-11:30 E Room 2 Sept. 28 (Thu.) 9:00-11:30 E Translational research based on clinical trials New trends for studying cancer invasion and metastasis CS1 S1 臨床試験からつなげるトランスレーショナルリサーチ がんの浸潤・転移研究の新機軸 Chairpersons: Tony Mok (Chinese Univ. of Hong-Kong) Chairpersons: Nobuyuki Takakura (Dept. of Signal Transduction, RIMD, Osaka Atsushi Ohtsu (Natl. Cancer Ctr. Hosp. East) Univ.) 座長： Tony Mok (Chinese Univ. of Hong-Kong) Hisataka Sabe (Dept. of Mol. Biol., Hokkaido Univ., Grad. Sch. of 大津 敦（国立がん研セ・東病院） Med.) Recent progress on various analytical methods make researchers possible to 座長：高倉 伸幸（大阪大・微研・情報伝達） access precise information of not only tumor itself but tumor microenviron- 佐邊 壽孝（北海道大・院医・分子生物学分野） ment. Next generation sequencer (NGS) panels have changed recent clinical Greater understanding on tumor invasion and metastasis still continuously trial designs like umbrella/basket type studies. Immuno-oncology agents show us a new phase of malignancies of this disease. For example, cancer is have also provided remarkable impacts in cancer therapy, which require fur- now recognized as a metabolic disease, in which the major targets of oncogene ther investigation of immune-related biomarkers including immunity/cross products are cellular metabolism and the reprogramming. Complicated talk in tumor microenvironments for personalized medicine.
    [Show full text]
  • RIKEN IMS Annual Report  RIKEN Center for Integrative Medical Sciences  T Jp English/ Jp
    RIKEN IM S Annual RIKEN Center for Repo Integrative Medical Sciences http://www.ims.riken.jp/english/ r t RIKEN Yokohama Campus 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan RIKEN Center for Integrative Medical Sciences Integrative Medical for Center RIKEN Tel : 045-503-9111 Fax : 045-503-9113 Email : [email protected] RIKEN IMS Annual Report RIKEN IMS Annual Report RIKEN Center for Integrative Medical Sciences RIKEN - RIKEN Center for Integrative Medical Sciences Access to RIKEN Yokohama Campus Organization Chart Local Access RIKEN President By Bus Take the #08 bus from Platform 8 at the East Exit of Hiroshi Matsumoto Tsurumi Station (also accessible from the West Exit of Keikyu Tsurumi Station) and get off at the RIKEN Shidai Daigakuin Mae bus stop. The institute is across the street. All buses from this platform are bound for Fureyu. Director Buses depart Tsurumi every 5–15 minutes. It takes about 15 minutes to arrive at RIKEN Yokohama. The Tadashi Yamamoto fare is 220 yen. By Train A 15-minute walk from JR Tsurumi-Ono Station (JR Tsurumi Line), which is directly accessible by transfer Integrative Senior Advisor from JR Tsurumi Station. Medical Sciences rains run about every 10 minutes during morning and Planning Oce Masaru Taniguchi evening rush hour, but less frequently at other times. Shizuo Akira Searchable train timetables in English are available at http://www.hyperdia.com/en/ By Taxi Use the taxi stand at the East Exit of JR Tsurumi Station or the West Exit of Keikyu Tsurumi Station. The trip takes about 10 minutes and costs around 1,200 yen.
    [Show full text]